<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36087363</PMID><DateCompleted><Year>2022</Year><Month>11</Month><Day>16</Day></DateCompleted><DateRevised><Year>2023</Year><Month>01</Month><Day>03</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1872-7123</ISSN><JournalIssue CitedMedium="Internet"><Volume>317</Volume><PubDate><Year>2022</Year><Month>Nov</Month></PubDate></JournalIssue><Title>Psychiatry research</Title><ISOAbbreviation>Psychiatry Res</ISOAbbreviation></Journal><ArticleTitle>Larger gray matter volumes in neuropsychiatric long-COVID syndrome.</ArticleTitle><Pagination><StartPage>114836</StartPage><MedlinePgn>114836</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.psychres.2022.114836</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0165-1781(22)00429-2</ELocationID><Abstract><AbstractText>Neuropsychiatric symptoms are the most common sequelae of long-COVID. As accumulating evidence suggests an impact of survived SARS-CoV-2-infection on brain physiology, it is necessary to further investigate brain structural changes in relation to course and neuropsychiatric symptom burden in long-COVID. To this end, the present study investigated 3T-MRI scans from long-COVID patients suffering from neuropsychiatric symptoms (n&#xa0;=&#xa0;30), and healthy controls (n&#xa0;=&#xa0;20). Whole-brain comparison of gray matter volume (GMV) was conducted by voxel-based morphometry. To determine whether changes in GMV are predicted by neuropsychiatric symptom burden and/or initial severity of symptoms of COVID-19 and time since onset of COVID-19 stepwise linear regression analysis was performed. Significantly enlarged GMV in long-COVID patients was present in several clusters (spanning fronto-temporal areas, insula, hippocampus, amygdala, basal ganglia, and thalamus in both hemispheres) when compared to controls. Time since onset of COVID-19 was a significant regressor in four of these clusters with an inverse relationship. No associations with clinical symptom burden were found. GMV alterations in limbic and secondary olfactory areas are present in long-COVID patients and might be dynamic over time. Larger samples and longitudinal data in long-COVID patients are required to further clarify the mediating mechanisms between COVID-19, GMV and neuropsychiatric symptoms.</AbstractText><CopyrightInformation>Copyright &#xa9; 2022 The Authors. Published by Elsevier B.V. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Besteher</LastName><ForeName>Bianca</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of Psychiatry and Psychotherapy, Jena University Hospital, Philosophenweg 3, Jena 07743, Germany. Electronic address: bianca.besteher@med.uni-jena.de.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Machnik</LastName><ForeName>Marlene</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Psychiatry and Psychotherapy, Jena University Hospital, Philosophenweg 3, Jena 07743, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Troll</LastName><ForeName>Marie</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Psychiatry and Psychotherapy, Jena University Hospital, Philosophenweg 3, Jena 07743, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Toepffer</LastName><ForeName>Antonia</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Psychiatry and Psychotherapy, Jena University Hospital, Philosophenweg 3, Jena 07743, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zerekidze</LastName><ForeName>Ani</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Psychiatry and Psychotherapy, Jena University Hospital, Philosophenweg 3, Jena 07743, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rockt&#xe4;schel</LastName><ForeName>Tonia</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Psychiatry and Psychotherapy, Jena University Hospital, Philosophenweg 3, Jena 07743, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Heller</LastName><ForeName>Carina</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Psychiatry and Psychotherapy, Jena University Hospital, Philosophenweg 3, Jena 07743, Germany; Department of Psychiatry, Brigham and Women's Hospital, Harvard Medical School, Boston, USA; Department of Clinical Psychology, Friedrich-Schiller-University Jena, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kikinis</LastName><ForeName>Zora</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Department of Psychiatry, Brigham and Women's Hospital, Harvard Medical School, Boston, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Brodoehl</LastName><ForeName>Stefan</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Neurology, Jena University Hospital, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Finke</LastName><ForeName>Kathrin</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Neurology, Jena University Hospital, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Reuken</LastName><ForeName>Philipp A</ForeName><Initials>PA</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine IV, Gastroenterology, Hepatology and Infectious Diseases, Jena University Hospital, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Opel</LastName><ForeName>Nils</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Psychiatry and Psychotherapy, Jena University Hospital, Philosophenweg 3, Jena 07743, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Stallmach</LastName><ForeName>Andreas</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine IV, Gastroenterology, Hepatology and Infectious Diseases, Jena University Hospital, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gaser</LastName><ForeName>Christian</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Psychiatry and Psychotherapy, Jena University Hospital, Philosophenweg 3, Jena 07743, Germany; Department of Neurology, Jena University Hospital, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Walter</LastName><ForeName>Martin</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Psychiatry and Psychotherapy, Jena University Hospital, Philosophenweg 3, Jena 07743, Germany.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>09</Month><Day>06</Day></ArticleDate></Article><MedlineJournalInfo><Country>Ireland</Country><MedlineTA>Psychiatry Res</MedlineTA><NlmUniqueID>7911385</NlmUniqueID><ISSNLinking>0165-1781</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D066128" MajorTopicYN="Y">Gray Matter</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001921" MajorTopicYN="N">Brain</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008279" MajorTopicYN="N">Magnetic Resonance Imaging</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">Long-COVID</Keyword><Keyword MajorTopicYN="N">Neuroimaging</Keyword><Keyword MajorTopicYN="N">VBM</Keyword></KeywordList><CoiStatement>Declaration of Competing Interest Outside of the study, PAR received consulting and lecture fees from CSL Behring, Dr. Wilmar Schwabe, Boston Scientific, Pfizer, Bristol Myers Squibb and travel grants from Merz Pharma. All other authors state, that they have no conflict of interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>7</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2022</Year><Month>9</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>9</Month><Day>4</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>9</Month><Day>11</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>11</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>9</Month><Day>10</Day><Hour>18</Hour><Minute>14</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>9</Month><Day>6</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36087363</ArticleId><ArticleId IdType="pmc">PMC9444315</ArticleId><ArticleId IdType="doi">10.1016/j.psychres.2022.114836</ArticleId><ArticleId IdType="pii">S0165-1781(22)00429-2</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Antretter E., Dunkel D., Haring C. [The assessment of cognitive abilities in psychiatric patients: are widely used psychological tests still up-to-date?] Psychiatr Prax. 2013;40(3):120&#x2013;129.</Citation><ArticleIdList><ArticleId IdType="pubmed">23475778</ArticleId></ArticleIdList></Reference><Reference><Citation>Ashburner J. A fast diffeomorphic image registration algorithm. Neuroimage. 2007;38(1):95&#x2013;113.</Citation><ArticleIdList><ArticleId IdType="pubmed">17761438</ArticleId></ArticleIdList></Reference><Reference><Citation>Ashburner J., Friston K.J. Unified segmentation. Neuroimage. 2005;26(3):839&#x2013;851.</Citation><ArticleIdList><ArticleId IdType="pubmed">15955494</ArticleId></ArticleIdList></Reference><Reference><Citation>Banasr M., Sanacora G., Esterlis I. Macro- and microscale stress-associated alterations in brain structure: translational link with depression. Biol. Psychiatry. 2021;90(2):118&#x2013;127.</Citation><ArticleIdList><ArticleId IdType="pubmed">34001371</ArticleId></ArticleIdList></Reference><Reference><Citation>Beurel E., Toups M., Nemeroff C.B. The bidirectional relationship of depression and inflammation: double trouble. Neuron. 2020;107(2):234&#x2013;256.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7381373</ArticleId><ArticleId IdType="pubmed">32553197</ArticleId></ArticleIdList></Reference><Reference><Citation>Cohen J., Hillsdale N.J. 2nd ed. L. Erlbaum Associates; 1988. Statistical Power Analysis for the Behavioral Sciences.</Citation></Reference><Reference><Citation>Curtis M.A., Kam M., Nannmark U., Anderson M.F., Axell M.Z., Wikkelso C., Holtas S., van Roon-Mom W.M., Bjork-Eriksson T., Nordborg C., Frisen J., Dragunow M., Faull R.L., Eriksson P.S. Human neuroblasts migrate to the olfactory bulb via a lateral ventricular extension. Science. 2007;315(5816):1243&#x2013;1249.</Citation><ArticleIdList><ArticleId IdType="pubmed">17303719</ArticleId></ArticleIdList></Reference><Reference><Citation>Douaud G., Lee S., Alfaro-Almagro F., Arthofer C., Wang C., McCarthy P., Lange F., Andersson J.L.R., Griffanti L., Duff E., Jbabdi S., Taschler B., Keating P., Winkler A.M., Collins R., Matthews P.M., Allen N., Miller K.L., Nichols T.E., Smith S.M. SARS-CoV-2 is associated with changes in brain structure in UK Biobank. Nature. 2022</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9046077</ArticleId><ArticleId IdType="pubmed">35255491</ArticleId></ArticleIdList></Reference><Reference><Citation>Duan K., Premi E., Pilotto A., Cristillo V., Benussi A., Libri I., Giunta M., Bockholt H.J., Liu J., Campora R., Pezzini A., Gasparotti R., Magoni M., Padovani A., Calhoun V.D. Alterations of frontal-temporal gray matter volume associate with clinical measures of older adults with COVID-19. Neurobiol. Stress. 2021;14</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8041745</ArticleId><ArticleId IdType="pubmed">33869679</ArticleId></ArticleIdList></Reference><Reference><Citation>Frodl T., Amico F. Is there an association between peripheral immune markers and structural/functional neuroimaging findings? Prog. Neuropsychopharmacol. Biol. Psychiatry. 2014;48:295&#x2013;303.</Citation><ArticleIdList><ArticleId IdType="pubmed">23313563</ArticleId></ArticleIdList></Reference><Reference><Citation>Gellrich J., Stetzler C., Oleszkiewicz A., Hummel T., Schriever V.A. Olfactory threshold and odor discrimination ability in children - evaluation of a modified "Sniffin' Sticks" test. Sci. Rep. 2017;7(1)</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5434040</ArticleId><ArticleId IdType="pubmed">28512302</ArticleId></ArticleIdList></Reference><Reference><Citation>Groff D., Sun A., Ssentongo A.E., Ba D.M., Parsons N., Poudel G.R., Lekoubou A., Oh J.S., Ericson J.E., Ssentongo P., Chinchilli V.M. Short-term and long-term rates of postacute sequelae of SARS-CoV-2 infection: a systematic review. JAMA Netw. Open. 2021;4(10)</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8515212</ArticleId><ArticleId IdType="pubmed">34643720</ArticleId></ArticleIdList></Reference><Reference><Citation>Hammers A., Allom R., Koepp M.J., Free S.L., Myers R., Lemieux L., Mitchell T.N., Brooks D.J., Duncan J.S. Three-dimensional maximum probability atlas of the human brain, with particular reference to the temporal lobe. Hum. Brain Mapp. 2003;19(4):224&#x2013;247.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6871794</ArticleId><ArticleId IdType="pubmed">12874777</ArticleId></ArticleIdList></Reference><Reference><Citation>Han P., Zang Y., Akshita J., Hummel T. Magnetic resonance imaging of human olfactory dysfunction. Brain Topogr. 2019;32(6):987&#x2013;997.</Citation><ArticleIdList><ArticleId IdType="pubmed">31529172</ArticleId></ArticleIdList></Reference><Reference><Citation>Hutton C., Draganski B., Ashburner J., Weiskopf N. A comparison between voxel-based cortical thickness and voxel-based morphometry in normal aging. Neuroimage. 2009;48(2):371&#x2013;380.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2741580</ArticleId><ArticleId IdType="pubmed">19559801</ArticleId></ArticleIdList></Reference><Reference><Citation>Iqbal A., Iqbal K., Arshad Ali S., Azim D., Farid E., Baig M.D., Bin Arif T., Raza M. The COVID-19 sequelae: a cross-sectional evaluation of post-recovery symptoms and the need for rehabilitation of COVID-19 survivors. Cureus. 2021;13(2)</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7932827</ArticleId><ArticleId IdType="pubmed">33680620</ArticleId></ArticleIdList></Reference><Reference><Citation>Karstensen H.G., Vestergaard M., Baare W.F.C., Skimminge A., Djurhuus B., Ellefsen B., Bruggemann N., Klausen C., Leffers A.M., Tommerup N., Siebner H.R. Congenital olfactory impairment is linked to cortical changes in prefrontal and limbic brain regions. Brain Imaging Behav. 2018;12(6):1569&#x2013;1582.</Citation><ArticleIdList><ArticleId IdType="pubmed">29442274</ArticleId></ArticleIdList></Reference><Reference><Citation>Langan M.T., Smith D.A., Verma G., Khegai O., Saju S., Rashid S., Ranti D., Markowitz M., Belani P., Jette N., Mathew B., Goldstein J., Kirsch C.F.E., Morris L.S., Becker J.H., Delman B.N., Balchandani P. Semi-automated segmentation and quantification of perivascular spaces at 7 Tesla in COVID-19. Front. Neurol. 2022;13</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9010775</ArticleId><ArticleId IdType="pubmed">35432151</ArticleId></ArticleIdList></Reference><Reference><Citation>Lu Y., Li X., Geng D., Mei N., Wu P.Y., Huang C.C., Jia T., Zhao Y., Wang D., Xiao A., Yin B. Cerebral micro-structural changes in COVID-19 patients - an MRI-based 3-month follow-up study. EClinicalMedicine. 2020;25</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7396952</ArticleId><ArticleId IdType="pubmed">32838240</ArticleId></ArticleIdList></Reference><Reference><Citation>Matalon N., Dorman-Ilan S., Hasson-Ohayon I., Hertz-Palmor N., Shani S., Basel D., Gross R., Chen W., Abramovich A., Afek A., Ziv A., Kreiss Y., Pessach I.M., Gothelf D. Trajectories of post-traumatic stress symptoms, anxiety, and depression in hospitalized COVID-19 patients: a one-month follow-up. J. Psychosom. Res. 2021;143</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7885629</ArticleId><ArticleId IdType="pubmed">33618149</ArticleId></ArticleIdList></Reference><Reference><Citation>Mazza M.G., De Lorenzo R., Conte C., Poletti S., Vai B., Bollettini I., Melloni E.M.T., Furlan R., Ciceri F., Rovere-Querini P., group C.-B.O.C.S., Benedetti F. Anxiety and depression in COVID-19 survivors: role of inflammatory and clinical predictors. Brain Behav. Immun. 2020;89:594&#x2013;600.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7390748</ArticleId><ArticleId IdType="pubmed">32738287</ArticleId></ArticleIdList></Reference><Reference><Citation>Mazza M.G., Palladini M., De Lorenzo R., Magnaghi C., Poletti S., Furlan R., Ciceri F., group C.-B.O.C.S., Rovere-Querini P., Benedetti F. Persistent psychopathology and neurocognitive impairment in COVID-19 survivors: effect of inflammatory biomarkers at three-month follow-up. Brain Behav. Immun. 2021;94:138&#x2013;147.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7903920</ArticleId><ArticleId IdType="pubmed">33639239</ArticleId></ArticleIdList></Reference><Reference><Citation>Montgomery S.A., Smeyatsky N., de Ruiter M., Montgomery D.B. Profiles of antidepressant activity with the montgomery-asberg depression rating scale. Acta Psychiatr. Scand. 1985;320:38&#x2013;42. Suppl.</Citation><ArticleIdList><ArticleId IdType="pubmed">2931947</ArticleId></ArticleIdList></Reference><Reference><Citation>Najt P., Richards H.L., Fortune D.G. Brain imaging in patients with COVID-19: a systematic review. Brain Behav. Immun. Health. 2021;16</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8249107</ArticleId><ArticleId IdType="pubmed">34230916</ArticleId></ArticleIdList></Reference><Reference><Citation>Nasreddine Z.S., Phillips N.A., Bedirian V., Charbonneau S., Whitehead V., Collin I., Cummings J.L., Chertkow H. The montreal cognitive assessment, MoCA: a brief screening tool for mild cognitive impairment. J. Am. Geriatr. Soc. 2005;53(4):695&#x2013;699.</Citation><ArticleIdList><ArticleId IdType="pubmed">15817019</ArticleId></ArticleIdList></Reference><Reference><Citation>Netland J., Meyerholz D.K., Moore S., Cassell M., Perlman S. Severe acute respiratory syndrome coronavirus infection causes neuronal death in the absence of encephalitis in mice transgenic for human ACE2. J. Virol. 2008;82(15):7264&#x2013;7275.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2493326</ArticleId><ArticleId IdType="pubmed">18495771</ArticleId></ArticleIdList></Reference><Reference><Citation>Putri C., Arisa J., Hananto J.E., Hariyanto T.I., Kurniawan A. Psychiatric sequelae in COVID-19 survivors: a narrative review. World J. Psychiatry. 2021;11(10):821&#x2013;829.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8546765</ArticleId><ArticleId IdType="pubmed">34733644</ArticleId></ArticleIdList></Reference><Reference><Citation>Rajapakse J.C., Giedd J.N., Rapoport J.L. Statistical approach to segmentation of single-channel cerebral MR images. IEEE Trans. Med Imaging. 1997;16(2):176&#x2013;186.</Citation><ArticleIdList><ArticleId IdType="pubmed">9101327</ArticleId></ArticleIdList></Reference><Reference><Citation>Raji C.A., Ly M., Benzinger T.L.S. Overview of MR imaging volumetric quantification in neurocognitive disorders. Top Magn. Reson. Imaging. 2019;28(6):311&#x2013;315.</Citation><ArticleIdList><ArticleId IdType="pubmed">31794503</ArticleId></ArticleIdList></Reference><Reference><Citation>Rolls E.T. Limbic systems for emotion and for memory, but no single limbic system. Cortex. 2015;62:119&#x2013;157.</Citation><ArticleIdList><ArticleId IdType="pubmed">24439664</ArticleId></ArticleIdList></Reference><Reference><Citation>Schou T.M., Joca S., Wegener G., Bay-Richter C. Psychiatric and neuropsychiatric sequelae of COVID-19 - a systematic review. Brain Behav. Immun. 2021;97:328&#x2013;348.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8363196</ArticleId><ArticleId IdType="pubmed">34339806</ArticleId></ArticleIdList></Reference><Reference><Citation>Sheehan D.V., Lecrubier Y., Sheehan K.H., Amorim P., Janavs J., Weiller E., Hergueta T., Baker R., Dunbar G.C. The mini-international neuropsychiatric interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J. Clin. Psychiatry. 1998;59(Suppl 20):22&#x2013;33. quiz 34-57.</Citation><ArticleIdList><ArticleId IdType="pubmed">9881538</ArticleId></ArticleIdList></Reference><Reference><Citation>Spielberger C.D., Vagg P.R. Psychometric properties of the STAI: a reply to Ramanaiah, Franzen, and Schill. J. Pers Assess. 1984;48(1):95&#x2013;97.</Citation><ArticleIdList><ArticleId IdType="pubmed">6707862</ArticleId></ArticleIdList></Reference><Reference><Citation>Spisak T., Spisak Z., Zunhammer M., Bingel U., Smith S., Nichols T., Kincses T. Probabilistic TFCE: a generalized combination of cluster size and voxel intensity to increase statistical power. Neuroimage. 2019;185:12&#x2013;26.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6834440</ArticleId><ArticleId IdType="pubmed">30296561</ArticleId></ArticleIdList></Reference><Reference><Citation>Storsve A.B., Fjell A.M., Tamnes C.K., Westlye L.T., Overbye K., Aasland H.W., Walhovd K.B. Differential longitudinal changes in cortical thickness, surface area and volume across the adult life span: regions of accelerating and decelerating change. J. Neurosci. 2014;34(25):8488&#x2013;8498.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6608217</ArticleId><ArticleId IdType="pubmed">24948804</ArticleId></ArticleIdList></Reference><Reference><Citation>Theoharides T.C. Could SARS-CoV-2 spike protein be responsible for long-COVID syndrome? Mol. Neurobiol. 2022;59(3):1850&#x2013;1861.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8757925</ArticleId><ArticleId IdType="pubmed">35028901</ArticleId></ArticleIdList></Reference><Reference><Citation>Tohka J., Zijdenbos A., Evans A. Fast and robust parameter estimation for statistical partial volume models in brain MRI. Neuroimage. 2004;23(1):84&#x2013;97.</Citation><ArticleIdList><ArticleId IdType="pubmed">15325355</ArticleId></ArticleIdList></Reference><Reference><Citation>Tu Y., Zhang Y., Li Y., Zhao Q., Bi Y., Lu X., Kong Y., Wang L., Lu Z., Hu L. Post-traumatic stress symptoms in COVID-19 survivors: a self-report and brain imaging follow-up study. Mol. Psychiatry. 2021</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8290134</ArticleId><ArticleId IdType="pubmed">34285348</ArticleId></ArticleIdList></Reference><Reference><Citation>Whitmore H.A.B., Kim L.A. Understanding the role of blood vessels in the neurologic manifestations of coronavirus disease 2019 (COVID-19) Am. J. Pathol. 2021;191(11):1946&#x2013;1954.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8193973</ArticleId><ArticleId IdType="pubmed">34126084</ArticleId></ArticleIdList></Reference><Reference><Citation>World Health Organization-Global Forum for Health Research - Mental Health Research Mapping Project, G., 2020. Clinical management of COVID-19: interim guidance, 27 May 2020. 10665/26723.</Citation></Reference><Reference><Citation>Yong S.J. Long COVID or post-COVID-19 syndrome: putative pathophysiology, risk factors, and treatments. Infect. Dis. 2021;53(10):737&#x2013;754. (Lond)</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8146298</ArticleId><ArticleId IdType="pubmed">34024217</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao Y.J., Jin Y., Rao W.W., Li W., Zhao N., Cheung T., Ng C.H., Wang Y.Y., Zhang Q.E., Xiang Y.T. The prevalence of psychiatric comorbidities during the SARS and COVID-19 epidemics: a systematic review and meta-analysis of observational studies. J. Affect. Disord. 2021;287:145&#x2013;157.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7948672</ArticleId><ArticleId IdType="pubmed">33799032</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>